Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

211 filings reported holding AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value as of Q2 2021.
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 49,010,949 shares of 130,702,820 outstanding shares and own 37.5% of the company stock.
Largest 10 shareholders include FMR LLC (8,523,004 shares), ORBIMED ADVISORS LLC (6,069,032 shares), NEA Management Company, LLC (5,172,683 shares), MORGAN STANLEY (3,621,692 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (2,416,482 shares), PICTET ASSET MANAGEMENT LTD (2,170,394 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1,583,208 shares), BAKER BROS. ADVISORS LP (1,119,962 shares), Artal Group S.A. (1,000,000 shares), and WELLS FARGO & COMPANY/MN (788,283 shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.